16例化脓性眼内炎玻璃体切割联合玻璃体腔注药的回顾性分析

来源 :中国中医眼科杂志 | 被引量 : 0次 | 上传用户:supphia
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨玻璃体切割术联合玻璃体腔注药治疗化脓性眼内炎的临床疗效。方法收集化脓性眼内炎18例(18只眼),其中16只眼进行了玻璃体切除术联合玻璃体腔注药,2只眼单纯应用抗生素、皮质类固醇激素进行眼局部及全身的用药治疗,术后随访1~6个月。结果行玻璃体切割术联合玻璃体腔注药的16只眼中,13只眼矫正视力有不同程度提高(81.25%),1只眼(6.25%)视力没改变,2只眼(12.5%)视力降低;其中视力>0.5者2只眼,视力在0.1~0.5者5只眼,视力<0.1者6只眼,眼前数指2只眼,无光感1只眼。单纯应用药物治疗的2只眼因炎症反应较重,导致视力丧失,眼球萎缩。结论对于化脓性眼内炎,玻璃体切割术联合玻璃体腔注药的治疗效果明显优于单纯应用药物治疗,早期诊断、及时治疗是挽救眼球和视功能的关键。 Objective To investigate the clinical efficacy of vitrectomy combined with vitreous cavity injection in the treatment of suppurative endophthalmitis. Methods Eighteen eyes (18 eyes) with purulent endophthalmitis were collected. Vitrectomy and vitreous cavity injection were performed in 16 eyes. Local and systemic drug therapy was given in 2 eyes with antibiotics and corticosteroids alone. Follow-up 1 ~ 6 months. Results Among the 16 eyes treated with vitrectomy combined with intravitreal injection, the corrected visual acuity was improved to 81.25% in 13 eyes, unchanged in 1 eyes (6.25%), and decreased in 2 eyes (12.5%). Including visual acuity> 0.5 in 2 eyes, visual acuity in 0.1 to 0.5 in 5 eyes, visual acuity <0.1 in 6 eyes, the number of eyes refers to 2 eyes, no light perception in 1 eye. Simple application of drug treatment of the two eyes due to severe inflammatory reactions, resulting in loss of vision, eye atrophy. Conclusion For suppurative endophthalmitis, vitrectomy combined with intravitreal injection is superior to drug therapy alone. Early diagnosis and prompt treatment are the keys to salvage the eye and visual function.
其他文献
目的探讨转化生长因子(TGF)-β1对巨噬细胞内胆固醇酯水解酶(CEH)表达的影响。方法通过Ad-TGF-β1转染巨噬细胞,作用24、48、72 h后,采用Realtime-PCR、Q-PCR和Western印迹法
目的探讨角膜辅助切口在角膜穿通伤缝合术中的作用。方法对68例(68只眼)角膜穿通伤患者,在角膜裂口的对侧角膜缘内1 mm处作平行于角膜裂伤口的辅助切口,利用该切口注入黏弹剂
永宏PLC是一款定位于中小型市场的产品,在伺服多轴运动控制上有着广泛的运用,取得了良好的成绩,本文通过五轴高速控制系统来阐述永宏PLC在多轴定位控制上的应用。
目的研究中药复方“石芍明目散”对糖尿病性白内障(DC)大鼠抗氧化损伤的影响。方法将Wistar大鼠100只随机分为对照组A、模型组B、石芍预防组C、石芍治疗组D、阳性对照组E,每组2